Clinical Trials Browser

Suspended × Small Cell Lung Carcinoma × durvalumab × Clear all

NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Phase 1 Suspended

Lung Neoplasms, Small Cell Lung Carcinoma